Form 8-K - Current report:
SEC Accession No. 0001193125-24-237582
Filing Date
2024-10-15
Accepted
2024-10-15 16:05:59
Documents
13
Period of Report
2024-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d729291d8k.htm   iXBRL 8-K 24026
  Complete submission text file 0001193125-24-237582.txt   145577

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atra-20241014.xsd EX-101.SCH 2855
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atra-20241014_lab.xml EX-101.LAB 17996
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atra-20241014_pre.xml EX-101.PRE 11265
15 EXTRACTED XBRL INSTANCE DOCUMENT d729291d8k_htm.xml XML 3656
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 241371891
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)